Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Atoptic Dermatitis

In brief

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.

Key facts

Study ID
NCT07150845
Run by
Evommune, Inc.
People needed
120
Starts
2025-08-26
Expected to finish
2026-07-01
Last updated by the study team
2026-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.